Cellino Hosts Second Annual Personalized RegenMed Forum to Accelerate Progress in Regenerative Medicine [Yahoo! Finance]
Nevro Corp. (NYSE: NVRO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
NVRO Stock Declines Despite Positive Study Data of Nevro1 System [Yahoo! Finance]
New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches [Yahoo! Finance]
New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches